Trials / Unknown
UnknownNCT00885404
Chloride High Level Of Resuscitation Infusion Chloride High Level Of Resuscitation Infusion Delivered Evaluation
A Prospective, Before and After Study of the Impact of Lower Chloride Intravenous Fluid Management on Patients' Acid-base Status, Renal Profile,Length of Stay and Mortality.
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 7,000 (estimated)
- Sponsor
- Austin Health · Other Government
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether intravenous fluid management using lower chloride solutions (Hartmann's solutions and Plasmalyte®) will result in better outcome when compared to management using high chloride solutions (0.9% saline and Gelofusine®).
Detailed description
This is a prospective, controlled, before-and-after study. The baseline pre-intervention period will include collection of data while doctors and nurses are unaware that such collection is taking place. During this time, high chloride fluids (saline, Gelofusine, 4% albumin) will continue to be used according to standard practice with an estimated 30,000 liters of saline as well as 2,000 bottles of Gelofusine® being consumed. Following a wash out period of education and preparation, there will be a complete shift to a working environment where use of saline, Gelofusine and any other fluids with a high chloride level (\>110 mmol/L)will be restricted and substituted with fluids of lower chloride concentration similar to blood; either Hartmann's solution or Plasmalyte® or 20% albumin. The study will compare a 6 month control period (before) and a six month intervention period (after).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lower chloride fluids (Hartmann's solution and Plasmalyte®) | Intravenous fluids used during the 6 month intervention period (after). Amount of fluids to be used is based on clinicians' discretion. |
Timeline
- Start date
- 2009-02-01
- Primary completion
- 2009-08-01
- Completion
- 2010-08-01
- First posted
- 2009-04-22
- Last updated
- 2010-02-25
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT00885404. Inclusion in this directory is not an endorsement.